Healthcare · Biotechnology · NASDAQ
| Market cap | $1.31B |
|---|---|
| Trailing P/E | — |
| FCF yield | -18.2% |
| Revenue growth (YoY) | +64.7% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Novavax, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Pat Roberts | Senate | Sell | $1,001 - $15,000 | — |
| Pat Roberts | Senate | Buy | $1,001 - $15,000 | — |